Mercury Laboratories fixes book closure for ₹3.50 dividend
Mercury Laboratories Limited announced a book closure from September 22, 2026, to September 28, 2026, for its 45th Annual General Meeting and the payment of a final dividend of ₹3.50 per share. The record date for dividend eligibility is September 21, 2026. The company previously reported a 53.7% rise in FY26 net profit to ₹483.40 crore.

*this image is generated using AI for illustrative purposes only.
Mercury Laboratories Limited announced that its Register of Members and Share Transfer books will remain closed from September 22, 2026, to September 28, 2026, for the 45th Annual General Meeting and the payment of the final dividend. The company has fixed September 21, 2026, as the record date to determine shareholder eligibility for the dividend payout of ₹3.50 per share, subject to approval at the AGM scheduled for September 28, 2026.
The board had previously recommended the final dividend of ₹3.50 per share alongside the financial results for the year ended March 31, 2026. The AGM will be conducted via Video Conferencing. The dividend payment is contingent upon shareholder approval during the meeting.
Book Closure and AGM Details
| Particulars | Details |
|---|---|
| Book Closure From | September 22, 2026 |
| Book Closure To | September 28, 2026 |
| Record Date | September 21, 2026 |
| AGM Date | September 28, 2026 |
| Dividend | ₹3.50 per share |
The company reported a 53.7% increase in net profit to ₹483.40 crore for FY26, compared to ₹314.49 crore in the previous year. Revenue from operations rose to ₹7,593.67 crore from ₹7,510.12 crore in FY25.
Historical Stock Returns for Mercury Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +9.25% | +10.77% | +0.15% | -0.75% | +14.05% |
How will the proposed ₹3.50 dividend impact Mercury Laboratories' free cash flow and capital allocation plans for FY27?
Given the 53.7% profit surge, is the company considering increasing its dividend payout ratio in future fiscal years?
What strategic initiatives or market factors drove the significant net profit growth relative to the modest revenue increase?
































